Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation
Abstract Background Phosphoglucomutase 1 (PGM1) acts as an important regulator in glucose metabolism. However, the role of PGM1 in gastric cancer (GC) remains unclear. This study aims to investigate the role of PGM1 and develop novel regimens based on metabolic reprogramming in GC. Methods Correlati...
Main Authors: | Bo Cao, Huan Deng, Hao Cui, Ruiyang Zhao, Hanghang Li, Bo Wei, Lin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-02193-3 |
Similar Items
-
PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway
by: Zhewen Zheng, et al.
Published: (2022-05-01) -
PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
by: Yifan Sun, et al.
Published: (2019-10-01) -
Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer
by: Guangxu Xu, et al.
Published: (2023-08-01) -
Low-dose orlistat promotes the therapeutic effect of oxaliplatin in colorectal cancer
by: Qing Zhang, et al.
Published: (2022-09-01) -
Orlistat induces weight loss and improves fertility in patients with PCOS
by: Svetlana Yur'evna Vorotnikova
Published: (2015-04-01)